|
Title
|
Published
|
Price
|
|
Pharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply
By: Urch Publishing
"Each day millions of patients across Europe rely on the supply chain to deliver the medicines they need"
Pharmaceutical Distribution in Europe - The Emergence of Direct-to-Pharmacy Supply from URCH Publishing, is a
|
more...
|
2/1/2008
|
$2,084.00
|
|
2007 Pharmaceutical Product Approval Trends: Key Market Benchmarks and Strategic Insights
By: Urch Publishing
Pharmaceutical Product Approval Trends 2007: Key market benchmarks and strategic insights presents a detailed analysis of the new pharmaceutical products approved globally.
The 120-page report outlines the key therapeutic markets, significant pharmaceutical entities which
|
more...
|
12/1/2007
|
$2,699.00
|
|
Pharmaceutical Market Trends, 2007 - 2011
By: Urch Publishing
The report methodology provides a detailed but transparent analysis of key pharmaceutical market trends, including key markets, therapy areas, products and companies. Historical trends are formed over a three-year time horizon and future forecasts are
|
more...
|
11/1/2007
|
$2,078.00
|
|
Cardiovascular Pharmaceutical Market Trends, 2007 to 2010 - Key Market Forecasts and Growth Opportunities
By: Urch Publishing
The global cardiovascular market grew to US$89.7 billion in 2005, a year-on-year increase of 9.6%.
The global cardiovascular market is forecast to expand to US$116.3 billion in 2010, equivalent to a CAGR of 5.3%
|
more...
|
8/1/2007
|
$1,811.23
|
|
CNS Market Trends, 2007 to 2010
By: Urch Publishing
The global market for drugs treating Central Nervous System (CNS) disorders has grown rapidly in recent years to reach US$55.5 billion in 2005, a year-on-year increase of 6.6%.
Between 2003 and 2005, global
|
more...
|
6/1/2007
|
$2,110.00
|
|
Generic Competition 2007 to 2011: The impact of patent expiries on sales of major drugs
By: Urch Publishing
New generics in the period 2007 to 2011 threaten $100 billion of revenues generated in the United States and Europe. The most dramatic change in this period will arise in the period 2010 to 2012
|
more...
|
2/1/2007
|
$2,697.00
|
|
Cancer Market Trends 2006 - 2010
By: Urch Publishing
The global cancer market has just seen a period of rapid growth. Between 2003 and 2005, global sales for cancer treating drugs increased by 40% and now account for more than eight percent of total
|
more...
|
12/1/2006
|
$2,071.00
|
|
Pharmaceutical Market Trends, 2006-2010: Key Market Forecasts and Growth Opportunities
By: Urch Publishing
Summary
Pharmaceutical Market Trends, 2006: Key market forecasts & growth opportunities presents a detailed trend analysis of the global pharmaceutical market as at the end of 2005 and forecasts until 2010. The 170 page report
|
more...
Search inside this report
|
6/1/2006
|
$1,791.00
|
|
Preparing Health Technology Submissions for Pharmaceutical Products
By: Urch Publishing
This essential report will help you:
Prepare a global dossier to ensure successful formulary listing
Understand formulary submission guidelines in Australia, UK and USA
Respond to emerging evidentiary and analytical standards
Structure your
|
more...
Search inside this report
|
4/1/2006
|
$2,790.00
|
|
Major Pharmaceutical Markets of the Middle East
By: Urch Publishing
Major Pharmaceutical Markets of the Middle East is a comprehensive report providing extensive coverage of one of the strongest emerging markets. Through quality analysis and forecasts, this unique report will allow you to identify market
|
more...
Search inside this report
|
4/1/2006
|
$1,432.20
|
|
The Guide to Pharmaceutical Pricing & Reimbursement Systems: Western Europe
By: Urch Publishing
National pharmaceutical pricing and reimbursement is a complex and ever-changing area. In a rapidly globalising market it is essential that executives are briefed on the regulatory systems that determine the way in which your company
|
more...
Search inside this report
|
11/1/2005
|
$1,746.00
|
|
Generic Competition to 2009
By: Urch Publishing
“The period 2005 to 2009 will see the expiration of patent protection for 39 major drugs in the United States, an average of 8 a year. With 2004 seeing a decline in the number of
|
more...
Search inside this report
|
9/1/2005
|
$1,431.00
|
|
Pricing & Reimbursement of Medicines in the United Kingdom
By: Urch Publishing
National pharmaceutical pricing and reimbursement is a complex and ever-changing area. In a rapidly evolving market it is essential that executives are briefed on the regulatory systems that determine the way in which your company
|
more...
Search inside this report
|
6/1/2005
|
$810.00
|
|
Orphan Drugs to 2008: Understanding regulation and market opportunity in Europe
By: Urch Publishing
The report content will help all global companies to better understand the opportunities
presented by recent developments in Europe orphan drug legislation. Over the last 4 years
the legislation has provided opportunities for large and
|
more...
Search inside this report
|
1/1/2005
|
$1,791.00
|
|
Pharmaceutical Pricing
By: Urch Publishing
Pharmaceutical Pricing - Global Perspectives is a strategic report, that analyses all aspects of pharmaceutical pricing and reimbursement strategies through extensive use of case studies. The pricing of new pharmaceutical products is crucial and must
|
more...
|
9/1/2004
|
$1,170.00
|
|
Global Pharmaceutical Fine Chemicals
By: Urch Publishing
Global Pharmaceutical Fine Chemicals - Industry and Market Analysis, examines the development of the industry and outlines the issues that are shaping the industry of tomorrow. The 170 page report explains how fine chemicals companies
|
more...
Search inside this report
|
7/1/2004
|
$1,665.00
|
|
Research & Development in the Pharmaceutical Industry
By: Urch Publishing
Research & Development in the Pharmaceutical Industry - Options for success is a unique report that provides the latest information and insight into pharmaceutical industry research and development issues. This report analyses the key issues
|
more...
|
2/1/2004
|
$1,431.00
|
|
Parallel Trade in Pharmaceuticals
By: Urch Publishing
Parallel trade or parallel importation is the cross-border trade in a particular product, through a route that the manufacturer may not have originally intended. As many manufacturers operate a system whereby they sell their products
|
more...
Search inside this report
|
10/1/2003
|
$1,071.00
|
|
Opportunities in Drug Delivery
By: Urch Publishing
The formulation and delivery of drugs have played a crucial role in the development and commercialisation of pharmaceutical products during the last decade and none of the most commercially successful drugs have escaped the attention
|
more...
Search inside this report
|
9/1/2003
|
$720.00
|
|
Manufacturing in the Global Pharmaceuticals Industry Key drivers, company strategies and regulations
By: Urch Publishing
The pharmaceutical manufacturing industry is undergoing a period of major change, characterised by increased competition, industry globalisation and numerous mergers. The industry also faces multiple internal and external challenges such as high research and development
|
more...
Search inside this report
|
4/1/2003
|
$990.00
|
|
The Pharmaceutical Pricing Compendium - A Practical Guide To The Pricing And Reimbursement Of Medicines
By: Urch Publishing
Pricing and reimbursement is one of the most complicated and important business issues that the pharmaceuticals industry has to deal with.
Setting the right price and ensuring that the product is adequately reimbursed
|
more...
Search inside this report
|
3/1/2003
|
$225.00
|
|
Health Economics in the Drug Life Cycle: Achieving success in drug discovery, development, reimbursement and marketing
By: Urch Publishing
The increasingly cost-conscious nature of formulary decisions and the willingness of reimbursers to reject a drug for listing on budget impact grounds means that drug companies must address the issue of affordability at a very
|
more...
Buy by the section | Search inside this report
|
1/1/2003
|
$1,251.00
|
|
European Generic Drug Markets - Growth to 2007
By: Urch Publishing
The generic drug sector in Europe is poised for significant market growth over the next 5 years. Already generics account for 50% of all prescriptions and this is forecast to reach 75% by 2007.
|
more...
Buy by the section | Search inside this report
|
11/1/2002
|
$891.00
|
|
The Pharmaceutical Pricing and Reimbursement Systems of Central and Eastern Europe
By: Urch Publishing
In just ten years many Central and East European (CEE) countries have
brought their pharmaceuticals industry regulation in line with that of the
European Union. Pricing and reimbursement, however, continues to remain a
national issue.
|
more...
Buy by the section | Search inside this report
|
6/24/2002
|
$560.00
|
|
Emerging Pharmaceutical Markets - Potential & Problems
By: Urch Publishing
Drug regulators and representatives of the pharmaceutical
industry from the US, Europe and Japan have been
participating for nine years in the International Conference on
Harmonisation (ICH). The purpose is to eliminate duplicative
requirements for
|
more...
Buy by the section | Search inside this report
|
10/26/2001
|
$351.00
|
|
Title
|
Published
|
Price
|